Fast Facts About Anika Therapeutics, Inc.

President & CEO:	Charles H. Sherwood, Ph.D.
Founded:	1993
Employees:	114 as of December 31, 2010
Headquarters:	Bedford, MA
Exchange and Symbol:	NASDAQ Global Select Market ® under the symbol: ANIK
Areas of Focus:	Orthobiologics Relief of pain due to osteoarthritis; protection of soft tissues; and repair/regeneration of cartilage damage and defects Dermal Advanced wound care solutions and skin substitutes; and dermal fillers to reduce wrinkles Ophthalmic Viscoelastic used in intraocular surgery Veterinary Relief of pain due to osteoarthritis Anti-Adhesion Post-operative adhesion barriers and healing agents used in spinal, abdominal, and ear, nose and throat ("ENT") surgical procedures

Top Products:
Product Name	Disease/Condition
Orthovisc®	Osteoarthritis
Merogel®	Post-operative ENT procedure healing
Hyalograft® C Autograft	Cartilage regeneration
Hyalofast®	Cartilage regeneration
Hyalomatrix®	Wound healing
Hyalobarrier®	Post-operative adhesion barrier for abdominal indications
Hyvisc®	Equine osteoarthritis
Hyaloglide®	Post-operative adhesion barrier for hand surgery

Key Pipeline Products:
Product Name	Disease/Condition
Monovisc™	Osteoarthritis, pending U.S. PMA approval, and approved in Europe
Cingal™	Osteoarthritis, pre-clinical development
Hyalobone™	Bone tissue filler
Hyalospine™	Adhesion prevention post spinal surgery